Article
Emerging mutations and associated factors in patients displaying treatment failure on an etravirine-containing regimen.
Antiviral therapy - 1 Jan 2012
Marcelin Anne-Genevieve, Descamps Diane, Tamalet Catherine, Cottalorda Jacqueline, Izopet Jacques, Delaugerre Constance, Morand-Joubert Laurence, Trabaud Mary-Anne, Bettinger Dominique, Rogez Sylvie, Ruffault Annick, Henquell Cecile, Signori-Schmuck Anne, Bouvier-Alias Magali, Vallet Sophie, Masquelier Bernard, Flandre Philippe, Calvez Vincent
Abstract excerpt
BACKGROUND: The aim of this study was to characterize the mutations selected upon failure on etravirine (ETR)-containing regimen in non-nucleoside reverse transcriptase inhibitors (NNRTIs)-experienced HIV-infected patients and the associated factors. METHODS: Forty-two patients displaying virological failure after a 6 months ETR-containing regimen were studied. For each patient the reverse transcriptase (RT)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
